PT  - JOURNAL ARTICLE
AU  - Mandel, Ilana
AU  - Haves Ziv, Dana
AU  - Goldshtein, Ilana
AU  - Peretz, Tsuri
AU  - Alishekevitz, Dror
AU  - Fridman Dror, Anna
AU  - Hakim, Motti
AU  - Hashmueli, Sharon
AU  - Friedman, Itay
AU  - Sapir, Yair
AU  - Greco, Rita
AU  - Qu, Hongjing
AU  - Nestle, Frank
AU  - Wiederschain, Dmitri
AU  - Pao, Lily
AU  - Sharma, Sharad
AU  - Ben Moshe, Tehila
TI  - BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
AID  - 10.1136/jitc-2022-004859
DP  - 2022 Sep 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004859
VI  - 10
IP  - 9
4099  - http://jitc.bmj.com/content/10/9/e004859.short
4100  - http://jitc.bmj.com/content/10/9/e004859.full
SO  - J Immunother Cancer2022 Sep 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.